Intravesical Bacillus Calmette-Guérin (BCG) immunotherapy decreases the progression risk of non-muscle-invasive bladder cancer, but potentially yields a broad spectrum of side effects. We report the case of a 73-year-old man affected by miliary pulmonary BCG infection, whose microbiological diagnosis was probably hindered by empiric fluoroquinolones, focusing on imaging and clinical work-up.
Miliary pulmonary infection after BCG intravesical instillation: a rare, misdiagnosed and mistreated complication
CALLERIS, GIORGIO;Marra, Giancarlo;Corcione, Silvia;Oderda, Marco;Cardellino, Chiara;Audagnotto, Sabrina;Frea, Bruno;De Rosa, Francesco Giuseppe;Gontero, Paolo
Last
2017-01-01
Abstract
Intravesical Bacillus Calmette-Guérin (BCG) immunotherapy decreases the progression risk of non-muscle-invasive bladder cancer, but potentially yields a broad spectrum of side effects. We report the case of a 73-year-old man affected by miliary pulmonary BCG infection, whose microbiological diagnosis was probably hindered by empiric fluoroquinolones, focusing on imaging and clinical work-up.File in questo prodotto:
File | Dimensione | Formato | |
---|---|---|---|
Vol_25_4_2017_11.pdf
Accesso aperto
Tipo di file:
PDF EDITORIALE
Dimensione
107.91 kB
Formato
Adobe PDF
|
107.91 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.